Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients (Q85007256)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 September 2012

Language	Label	Description	Also known as
English	Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients	scientific article published on 21 September 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Federica Cavallo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Alessandra Larocca

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Lorenzo De Paoli

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Pellegrino Musto

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Roberto Freilone

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

P Falco

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

D Rossi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

T Guglielmelli

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Rocci

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Grasso

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M L M Siez

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Oliva

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Molica

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

R Mina

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

G Benevolo

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

P Omedè

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Bringhen

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A M Carella

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

G Gaidano

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Boccadoro

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Palumbo

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

21 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

695-701

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996335%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent major improvement in long-term survival of younger patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide for the treatment of B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.271

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85007256&oldid=2221698212"